
Experienced CRA III who has performed monitoring and site management activities in several therapeutic areas, adept at recognizing clinical values and abstract data from source documents, monitoring progress of clinical projects at assigned investigative/physician sites, ensuring clinical projects are conducted, recorded and reported in accordance with the protocol, company and sponsors standard operating procedures (SOPs) & ICH-GCP.
Oncology: (5 years) Lung 5 Phase III, Multiple Myeloma 3 Phase I/II, Lymphoma 3 Phase I/III, Multiple solid tumors dose finding and Escalation Phase II
Ophthalmology: Glaucoma Phase I/II,Diabetic Retinopathy Phase III.
Neurology/CNS: Schizophrenia Phase I/II, Huntington Disease Phase I/II, Parkinson Disease phase III
Infectious Diseases: (3 years) Flu Phase III, (2 years) Cystic Fibrosis Phase III
Medical Devices. (10years) Heart value, CGDM, EMR, EER, IVD, REDCap
Cardiovascular (4.5years) Hypertension, Myocardial Infraction